Trade IOVA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Iovance Biotherapeutics, Inc. (IOVA) is trading at US$8.79, up 1.03% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$3.76B. Over the past 52 weeks, IOVA has traded between US$1.76 and US$9.36. On Syfe you can trade IOVA with $0 commission and add it to your watchlist.
| Previous close | US$8.70 |
|---|---|
| Market cap | US$3.76B |
| 52-week range | US$1.76 – US$9.36 |
| Volume | 8.05M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.
Year: 2010
--Earnings Flash (IOVA) Iovance Biotherapeutics Posts Q2 Loss $0.11 a Share, vs. FactSet Est of $0.13 Loss
Aug 6, 11:51 AM · MT Newswires
-- Earnings Flash (IOVA) Iovance Biotherapeutics, Inc. Reports Q2 Revenue $99.3M, vs. FactSet Est of $87.8M
Aug 6, 11:17 AM · MT Newswires
Iovance Biotherapeutics, Inc. (IOVA) stock is trading at US$8.79, +1.03% from the previous close of US$8.70.
The market cap for Iovance Biotherapeutics, Inc. (IOVA) stock is approximately US$3.76B.
The 52-week high for Iovance Biotherapeutics, Inc. (IOVA) stock is US$9.36.
The 52-week low for Iovance Biotherapeutics, Inc. (IOVA) stock is US$1.76.
Iovance Biotherapeutics, Inc. (IOVA) does not currently pay a dividend.
Stay on top of IOVA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
